| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |